|Chemical and physical data|
|Molar mass||212.29g/mol g·mol−1|
|3D model (JSmol)|
Ergoline derivatives comprise a diverse group of chemical compounds whose structural skeleton is the alkaloid ergoline. Ergoline derivatives are used clinically for the purpose of vasoconstriction (5-HT1 receptor agonists—ergotamine) and in the treatment and alleviation of migraines (used with caffeine) and Parkinson’s disease. Some ergoline alkaloids found in ergot fungi are implicated in the condition ergotism, which causes convulsive and gangrenous symptoms. Others are psychedelic substances, including LSD and some alkaloids in Argyreia nervosa, Ipomoea tricolor and related species.
In addition to the naturally occurring ergonovine (used as an oxytocic) and ergotamine (a vasoconstrictor used to control migraine), synthetic derivatives of importance are the oxytocic methergine, the anti-migraine drugs dihydroergotamine and methysergide, hydergine (a mixture of dihydroergotoxine mesylates, INN: ergoline mesylates), and bromocriptine, used for numerous purposes including treatment of Parkinson’s disease. Newer synthetic ergolines used for Parkinson’s disease include pergolide and lisuride.
Perhaps the most famous ergoline derivative is the psychedelic drug LSD. Ergometrine and ergotamine are included as schedule I precursors in the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
Ergoline alkaloids are found in lower fungi and some species of flowering plants: the Mexican species Turbina corymbosa and Ipomoea tricolor of the Convolvulaceae (morning glory) family, the seeds of which were identified as the psychedelic plant drugs known as “ololiuhqui” and “tlitliltzin”, respectively. The principal alkaloids in the seeds are ergine and its optical isomer isoergine, with several other lysergic acid derivatives and clavines present in lesser amounts. The Hawaiian species Argyreia nervosa includes similar alkaloids. It is possible, though not proven, that ergine or isoergine are responsible for the psychedelic effects. There may be a fungal origin of the ergoline alkaloids also in the Convolvulaceae. Like the ergot alkaloids in some monocot plants, the ergoline alkaloids found in the plant Ipomoea asarifolia (Convolvulaceae) are produced by a seed-transmitted endophytic clavicipitaceous fungus.
Ergoline alkaloids were first isolated from ergot, a fungus that infects grain and causes the disease ergotism. Ergot also has a long history of medicinal use, which led to attempts to characterize its activity chemically. This began in 1906 with the isolation by G. Barger and F. H. Carr of ergotoxine, so-named since it appeared to exhibit more of the toxicity of ergot than its therapeutic qualities. The isolation of ergotamine in 1918 by Arthur Stoll made possible the first therapeutic use of isolated ergoline alkaloids.
Lysergic acid amides
- Ergine (LSA, D-lysergic acid amide, LAA, LA-111)
- Ergonovine (ergobasine)
- Methergine (ME-277)
- INN: methylergometrine
- IUPAC name: (8beta(S))-9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-ergoline-8-carboxamide
- CAS number: 113-42-8
- Methysergide (UML-491)
- INN: methysergide
- IUPAC name: (8beta)-9,10-didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethyl-ergoline-8-carboxamide
- CAS number: 361-37-5
- LSD (D-lysergic acid diethylamide, LSD-25)
- INN: lysergide
- IUPAC name: (8beta)-9,10-didehydro-N,N-diethyl-6-methyl-ergoline-8-carboxamide
- CAS number: 50-37-3
- LSH (D-lysergic acid α-hydroxyethylamide)
- IUPAC name: 9,10-didehydro-N-(1-hydroxyethyl)-6-methylergoline-8-carboxamide
- CAS number: 3343-15-5
The relationship between these compounds is summarized in the following structural formula and table of substitutions.
Peptide ergot alkaloids or ergopeptines (also known as ergopeptides) are ergoline derivatives that contain a tripeptide structure attached to the basic ergoline ring in the same location as the amide group of the lysergic acid derivatives. This structure consists of proline and two other α-amino acids, linked in an unusual cyclol formation >N-C(OH)< with the carboxyl carbon of proline, at the juncture between the two lactam rings. Some of the important ergopeptines are summarized below. In addition to the following ergopeptines, a commonly encountered term is ergotoxine, which refers to a mixture of equal proportions of ergocristine, ergocornine and ergocryptine, the latter being a 2:1 mixture of alpha– and beta-ergocryptine.
- Ergotoxine group (valine as the amino acid attached to the ergoline moiety, at R2 below)
- IUPAC name: Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′,5′-bis(1-methylethyl)-, (5′-alpha)-
- CAS number: 564-36-3
- IUPAC name: Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-, (5’alpha)-
- CAS number: 511-09-1
- IUPAC name: Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(1-methylpropyl)-, (5’alpha(S))-
- CAS number: 20315-46-2
- Ergotamine group (alanine at R2)
- IUPAC name: Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′-alpha)-
- CAS number: 113-15-5
- IUPAC name: Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(1-methylethyl)-, (5’alpha)-
- CAS number: 2873-38-3
- IUPAC name: Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(2-methylpropyl)-, (5′-alpha)-
- CAS number: 561-94-4
- IUPAC name: Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(1-methylpropyl)-, (5′-alpha(S))-
- CAS number: 60192-59-8
|Name||R1||R2||R3||Amino acid at R3|
A variety of modifications to the basic ergoline are seen in nature, for example agroclavine, elymoclavine, lysergol. Those deriving from dimethylergoline are referred to as clavines. Examples of clavines, include festuclavine, fumigaclavine A, fumigaclavine B and fumigaclavine C.
Some synthetic ergoline derivatives do not fall easily into any of the above groups. Some examples are:
- Cabergoline (INN)
- Pergolide (INN)
- IUPAC name: (8β)-8-((methylthio)methyl)-6-propyl-ergoline
- CAS number: 66104-22-1
- Lisuride (INN)
- IUPAC name: 3-(9,10-didehydro-6-methylergolin-8α-yl)-1,1-diethylurea
- CAS number: 18016-80-3
- Juszczak, GR; Swiergiel, AH (2013). “Recreational use of D-lysergamide from the seeds of Argyreia nervosa, Ipomoea tricolor, Ipomoea violacea, and Ipomoea purpurea in Poland”. J Psychoactive Drugs. 45 (1): 79–93. doi:10.1080/02791072.2013.763570. PMID 23662334.
- http://www.incb.org/pdf/e/list/red.pdf Archived 2008-02-27 at the Wayback Machine.
- kidsgrowth.org –> Drugs and Other Substances in Breast Milk Archived 2007-06-23 at Archive.today Retrieved on June 19, 2009.
- Schardl CL, Panaccione DG, Tudzynski P (2006). “Ergot alkaloids – biology and molecular biology”. The Alkaloids: Chemistry and Biology. The Alkaloids: Chemistry and Biology. 63: 45–86. doi:10.1016/S1099-4831(06)63002-2. ISBN 978-0-12-469563-4. PMID 17133714.
- Carod-Artal, FJ (2015). “Hallucinogenic drugs in pre-Columbian Mesoamerican cultures”. Neurologia. 30 (1): 42–9. doi:10.1016/j.nrl.2011.07.003. PMID 21893367.
- Steiner, U; Ahimsa-Müller, MA; Markert, A; Kucht, S; Groß, J; Kauf, N; Kuzma, M; Zych, M; Lamshöft, M; Furmanowa, M; Knoop, V; Drewke, C; Leistner, E (2006). “Molecular characterization of a seed transmitted clavicipitaceous fungus occurring on dicotyledoneous plants (Convolvulaceae)”. Planta. 224 (3): 533–44. doi:10.1007/s00425-006-0241-0. PMID 16525783.
- G. Floss, Heinz (1976). “Biosynthesis of Ergot Alkaloids and Related Compounds”. Tetrahedron Report. 32 (14): 873 to 912. doi:10.1016/0040-4020(76)85047-8.
- Yates, S. G.; Plattner, R. D.; Garner, G. B. (1985). “Detection of ergopeptine alkaloids in endophyte-infected, toxic Ky-31 tall fescue by mass spectrometry/mass spectrometry” (PDF). Journal of Agricultural and Food Chemistry. 33 (4): 719. doi:10.1021/jf00064a038.[permanent dead link]
- The Ergot Alkaloids (A. T. Sneden)
- The Ergot Alkaloids Story (Z. Madlom)
- The Psychoactive Ergot Alkaloids and their occurrence in the Microfungi — M. P. Bock and D. G. Parbery
- Hofmann, A. Teonanácatl and Ololiuqui, two ancient magic drugs of Mexico Bulletin on Narcotics 1971 1 3
- TiHKAL (A & A Shulgin) #26